Tavassoli F, Schnitt S, Hoefler H (2003) Intraductal proliferative lesions. In: Tavassoli F, Devilee P (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC press, Lyon
Feyrter F (1963) On the carcinoid growth form of the carcinoma mammae, especially the carcinoma solidum (gelatinosum) mammae (in German). Frankf Z Pathol 73:24–39
Miremadi A, Pinder S, Lee A et al (2002) Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology 40(3):215–222
Article CAS PubMed Google Scholar
Gallo M, Campione S, Di Vito V et al (2021) Primary neuroendocrine neoplasms of the breast: still open issues. Front Endocrinol. https://doi.org/10.3389/fendo.2020.610230
Tan PH, Ellis I, Allison K et al (2020) The 2019 World Health Organization classification of tumours of the breast. Histopathology. https://doi.org/10.1111/his.14091
Article PubMed PubMed Central Google Scholar
Rindi G, Klimstra DS, Abedi-Ardekani B et al (2018) A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 31(12):1770–1786
Article PubMed PubMed Central Google Scholar
Pareja F, D’Alfonso TM (2020) Neuroendocrine neoplasms of the breast: a review focused on the updated World Health Organization (WHO) morphologic classification. Breast J 26(6):1160–1167
Yang L, Roy M, Lin H et al (2021) Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast. Breast Cancer Res Treat 186(2):403–415
Biganzoli E, Coradini D, Ambrogi F et al (2011) p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features. Jpn J Clin Oncol 41(2):172–179
Bean GR, Najjar S, Shin SJ et al (2022) Genetic and immunohistochemical profiling of small cell and large cell neuroendocrine carcinomas of the breast. Mod Pathol 35(10):1349–1361
Article CAS PubMed PubMed Central Google Scholar
Wang J, Wei B, Albarracin CT, Hu J, Abraham SC, Wu Y (2014) Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database. BMC Cancer 14:147
Article PubMed PubMed Central Google Scholar
Rovera F, Masciocchi P, Coglitore A et al (2008) Neuroendocrine carcinomas of the breast. Int J Surg 6:S113–S115
Lavigne M, Menet E, Tille J-C et al (2018) Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast. Mod Pathol 31(1):68–82
Article CAS PubMed Google Scholar
Tian Z, Wei B, Tang F et al (2011) Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol 42(8):1169–1177
Article CAS PubMed Google Scholar
Zekioglu O, Ylz Erhan, Çiriş M, Bayramoglu H (2003) Neuroendocrine differentiated carcinomas of the breast: a distinct entity. Breast. 12(4):251–257
Lopez-Bonet E, Alonso-Ruano M, Barraza G, Vazquez-Martin A, Bernado L, Menendez JA (2008) Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling. Oncol Rep 20(6):1369–1374
Lavigne M, Menet E, Tille J-C et al (2018) Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast. Mod Pathol 31(1):68–82
Article CAS PubMed Google Scholar
Koboldt D, Fulton R, McLellan M et al (2012) Comprehensive molecular portraits of human breast tumours. Nature 490(7418):61–70
Li J-p, Zhang X-m, Zhang Z, Zheng L-h, Jindal S, Liu Y-j (2019) Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma. Medicine. https://doi.org/10.1097/MD.0000000000015449
Article PubMed PubMed Central Google Scholar
Gasco M, Shami S, Crook T (2002) The p53 pathway in breast cancer. Breast Cancer Res 4(2):1–7
Ang D, Ballard M, Beadling C et al (2015) Novel mutations in neuroendocrine carcinoma of the breast: possible therapeutic targets. Appl Immunohistochem Mol Morphol 23(2):97–103
Article CAS PubMed Google Scholar
Marchiò C, Geyer FC, Ng CK et al (2017) The genetic landscape of breast carcinomas with neuroendocrine differentiation. J Pathol 241(3):405–419
Wei B, Ding T, Xing Y et al (2010) Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma. Cancer 116(19):4463–4473
Wei Y, Ke X, Yu J et al (2022) Clinical and genomic analyses of neuroendocrine neoplasms of the breast. Mod Pathol 35(4):495–505
Article CAS PubMed Google Scholar
Lakhani SR, Ellis IO, Schnitt S, Tan PH, van de Vijver M (2012) WHO classification of tumours of the breast. International Agency for Research on Cancer, Lyon
Tang F, Wei B, Tian Z et al (2011) Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges. Histopathology 59(1):106–115
Makuuchi R, Terashima M, Kusuhara M et al (2017) Comprehensive analysis of gene mutation and expression profiles in neuroendocrine carcinomas of the stomach. Biomed Res 38(1):19–27
Article CAS PubMed Google Scholar
Pizzi S, Azzoni C, Bassi D, Bottarelli L, Milione M, Bordi C (2003) Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract. Cancer Interdiscip Intern J Am Cancer Soc 98(6):1273–1282
Furlan D, Cerutti R, Uccella S et al (2004) Different molecular profiles characterize well-differentiated endocrine tumors and poorly differentiated endocrine carcinomas of the gastroenteropancreatic tract. Clin Cancer Res 10(3):947–957
Article CAS PubMed Google Scholar
Sahnane N, Furlan D, Monti M et al (2015) Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity. Endocr Relat Cancer 22(1):35–45
Article CAS PubMed Google Scholar
Chan AO-O, Kim SG, Bedeir A, Issa J-P, Hamilton SR, Rashid A (2003) CpG island methylation in carcinoid and pancreatic endocrine tumors. Oncogene 22(6):924–934
留言 (0)